Show simple item record

dc.contributor.authorDe Marco Verissimo, Carolina
dc.contributor.authorJewhurst, Heather L.
dc.contributor.authorTikhonova, Irina G.
dc.contributor.authorUrbanus, Rolf T.
dc.contributor.authorMaule, Aaron G.
dc.contributor.authorDalton, John P.
dc.contributor.authorCwiklinski, Krystyna
dc.date.accessioned2020-09-24T13:41:50Z
dc.date.available2020-09-24T13:41:50Z
dc.date.issued2020-08-06
dc.identifier.citationDe Marco Verissimo, Carolina, Jewhurst, Heather L., Tikhonova, Irina G., Urbanus, Rolf T., Maule, Aaron G., Dalton, John P., & Cwiklinski, Krystyna. (2020). Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases. PLOS Neglected Tropical Diseases, 14(8), e0008510. doi:10.1371/journal.pntd.0008510en_IE
dc.identifier.issn1935-2735
dc.identifier.urihttp://hdl.handle.net/10379/16185
dc.description.abstractSerine protease inhibitors (serpins) regulate proteolytic events within diverse biological processes, including digestion, coagulation, inflammation and immune responses. The presence of serpins in Fasciola hepatica excretory-secretory products indicates that the parasite exploits these to regulate proteases encountered during its development within vertebrate hosts. Interrogation of the F. hepatica genome identified a multi-gene serpin family of seven members that has expanded by gene duplication and divergence to create an array of inhibitors with distinct specificities. We investigated the molecular properties and functions of two representatives, FhSrp1 and FhSrp2, highly expressed in the invasive newly excysted juvenile (NEJ). Consistent with marked differences in the reactive centre loop (RCL) that executes inhibitor-protease complexing, the two recombinant F. hepatica serpins displayed distinct inhibitory profiles against an array of mammalian serine proteases. In particular, rFhSrp1 efficiently inhibited kallikrein (Ki = 40 nM) whilst rFhSrp2 was a highly potent inhibitor of chymotrypsin (Ki = 0.07 nM). FhSrp1 and FhSrp2 are both expressed on the NEJ surface, predominantly around the oral and ventral suckers, suggesting that these inhibitors protect the parasites from the harmful proteolytic effects of host proteases, such as chymotrypsin, during invasion. Furthermore, the unusual inhibition of kallikrein suggests that rFhSrp1 modulates host responses such as inflammation and vascular permeability by interfering with the kallikrein-kinin system. A vaccine combination of rFhSrp1 and rFhSrp2 formulated in the adjuvant Montanide ISA 206VG elicited modest but non-significant protection against a challenge infection in a rat model, but did induce some protection against liver pathogenesis when compared to a control group and a group vaccinated with two well-studied vaccine candidates, F. hepatica cathepsin L2 and L3. This work highlights the importance of F. hepatica serpins to regulate host responses that enables parasite survival during infection and, coupled with the vaccine data, encourages future vaccine trials in ruminants.en_IE
dc.description.sponsorshipThis study was funded by the Science Foundation Ireland (SFI, Republic of Ireland)-Department of Education and Learning (DEL, Northern Ireland) grant 14/IA/2304 and Science Foundation Ireland (SFI, Republic of Ireland) grant 17/RP/5368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherPublic Library of Scienceen_IE
dc.relation.ispartofPlos Neglected Tropical Diseasesen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectFasciola hepaticaen_IE
dc.subjectserine protease inhibitor family (serpins)en_IE
dc.subjectregulating host proteasesen_IE
dc.titleFasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteasesen_IE
dc.typeArticleen_IE
dc.date.updated2020-09-24T10:47:22Z
dc.identifier.doi10.1371/journal.pntd.0008510
dc.local.publishedsourcehttps://doi.org/10.1371/journal.pntd.0008510en_IE
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funderScience Foundation Irelanden_IE
dc.contributor.funderDepartment of Education and Learning, Northern Irelanden_IE
dc.internal.rssid22800945
dc.local.contactJohn Pius Dalton. Email: johnpius.dalton@nuigalway.ie
dc.local.copyrightcheckedYes
dcterms.projectinfo:eu-repo/grantAgreement/SFI/SFI Investigator Programme/14/IA/2304/IE/Application of New and Emerging Technologies to Develop Vaccines against Fasciola hepatica/en_IE
nui.item.downloads98


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland